Alopecia Areata Epidemiology Forecast

DelveInsight's 'Alopecia Areata - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Alopecia Areata epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Alopecia Areata Understanding

The DelveInsight Alopecia Areata epidemiology report gives a thorough understanding of the Alopecia Areata by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Alopecia Areata in the US, Europe, and Japan. The report covers the detailed information of the Alopecia Areata epidemiology scenario in seven major countries (US, EU5, and Japan).


Alopecia Areata Epidemiology Perspective by DelveInsight

The Alopecia Areata epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Alopecia Areata epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Alopecia Areata epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Alopecia Areata Detailed Epidemiology Segmentation

The Alopecia Areata epidemiology covered in the report provides historical as well as forecasted Alopecia Areata epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Alopecia Areata report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Alopecia Areata report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Alopecia Areata Epidemiology Report and Model provide an overview of the risk factors and global trends of Alopecia Areata in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Alopecia Areata in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Alopecia Areata
  • The report provides the segmentation of the Alopecia Areata epidemiology


Report Highlights

  • 11-Year Forecast of Alopecia Areata epidemiology
  • 7MM Coverage
  • Total Cases of Alopecia Areata
  • Total Cases of Alopecia Areata according to segmentation
  • Diagnosed cases of Alopecia Areata


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Alopecia Areata?
  • What are the key findings pertaining to the Alopecia Areata epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Alopecia Areata across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Alopecia Areata?
  • What are the currently available treatments of Alopecia Areata?


Reasons to buy

  • The Alopecia Areata Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Alopecia Areata market
  • Quantify patient populations in the global Alopecia Areata market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Alopecia Areata therapeutics in each of the markets covered
  • Understand the magnitude of Alopecia Areata population by its epidemiology
  • The Alopecia Areata Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Alopecia Areata

3. Alopecia Areata: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Alopecia Areata Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Alopecia Areata Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Alopecia Areata Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Alopecia Areata Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Alopecia Areata Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Alopecia Areata Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Alopecia Areata Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Alopecia Areata Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Alopecia Areata Treatment and Management

6.2. Alopecia Areata Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Alopecia Areata Epidemiology in 7MM (2017-2030)

Table 2 Alopecia Areata Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Alopecia Areata Epidemiology in the United States (2017-2030)

Table 4 Alopecia Areata Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Alopecia Areata Epidemiology in Germany (2017-2030)

Table 6 Alopecia Areata Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Alopecia Areata Epidemiology in France (2017-2030)

Table 8 Alopecia Areata Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Alopecia Areata Epidemiology in Italy (2017-2030)

Table 10 Alopecia Areata Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Alopecia Areata Epidemiology in Spain (2017-2030)

Table 12 Alopecia Areata Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Alopecia Areata Epidemiology in the United Kingdom (2017-2030)

Table 14 Alopecia Areata Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Alopecia Areata Epidemiology in Japan (2017-2030)

Table 16 Alopecia Areata Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Alopecia Areata Epidemiology in 7MM (2017-2030)

Figure 2 Alopecia Areata Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Alopecia Areata Epidemiology in the United States (2017-2030)

Figure 4 Alopecia Areata Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Alopecia Areata Epidemiology in Germany (2017-2030)

Figure 6 Alopecia Areata Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Alopecia Areata Epidemiology in France (2017-2030)

Figure 8 Alopecia Areata Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Alopecia Areata Epidemiology in Italy (2017-2030)

Figure 10 Alopecia Areata Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Alopecia Areata Epidemiology in Spain (2017-2030)

Figure 12 Alopecia Areata Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Alopecia Areata Epidemiology in the United Kingdom (2017-2030)

Figure 14 Alopecia Areata Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Alopecia Areata Epidemiology in Japan (2017-2030)

Figure 16 Alopecia Areata Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report



  • Tags:
  • Alopecia Areata Epidemiology
  • Alopecia Areata
  • Alopecia Areata Pipeline
  • Alopecia Areata Companies
  • Alopecia Areata prevalent populati...
  • Alopecia Areata incident populatio...
  • Alopecia Areata patients diagnosed
  • Alopecia Areata treatment algorith...

Forward to Friend

Need A Quote